Table 4.  Conclusion of the immunophenotyping assays

 

Pathology

 

n

%

Reactive lymphocytosis

5

12.8

Acute Leukemia

 

4

10.3

Chronic lymphoid malignancies

 

 

 

Myeloma or Plasma cell leukemia

1

2.6

Waldenström disease

1

2.6

NK proliferation

1

2.6

Chronic lymphocytic leukemia

8

20.5

Circulating phase of B cell non-Hodgkin’s lymphoma

19

48.6

Total

39

100